Non-pharmacological Pain Care During Complex Wound Care Procedures

Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05744024
Collaborator
(none)
180
1
3
24
7.5

Study Details

Study Description

Brief Summary

The main objective of this study is to evaluate the effect on pain and both Virtual Reality and Music Therapy as add-on therapy during wound care at the surgical wards in adults.

Condition or Disease Intervention/Treatment Phase
  • Device: Virtual Reality system
  • Other: Headphones
N/A

Detailed Description

After inclusion and completion of the informed consent form, patients are randomly allocated to the intervention group or control group in a 1:1:1 ratio. Randomization will not be blinded since both the provider and patient know if the patient will be wearing the VR system or headphone with audio during wound care or not wearing the VR system or headphone with audio.

Patients are randomly assigned to one of three groups:

Group 1 - Intervention group 1, Virtual Reality Therapy Group 2 - Intervention group 2, Music Therapy Group 3 - Control group, care as usual

Study Design

Study Type:
Interventional
Anticipated Enrollment :
180 participants
Allocation:
Randomized
Intervention Model:
Sequential Assignment
Masking:
None (Open Label)
Masking Description:
Randomization will not be blinded since both the provider and patient know if the patient will be wearing the VR system or headphone with audio during wound care or not wearing the VR system or headphone with audio.
Primary Purpose:
Treatment
Official Title:
Non-pharmacological Pain Care Using Virtual Reality Therapy or Music Therapy During Complex Wound Care in Adults at Surgical Nursing Wards
Actual Study Start Date :
Nov 17, 2022
Anticipated Primary Completion Date :
Nov 17, 2024
Anticipated Study Completion Date :
Nov 17, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Virtual Reality Therapy (Intervention group 1)

In addition to the standard wound care procedure, the Virtual Reality Therapy group (intervention group 1) will receive the VR system during the wound care. The VR system consists of Virtual Reality glasses, a controller and a headphone. The application SyncVR Relax & Distract will be used, which will contain various videos for the patient those from to relax and be distracted. This group wears the VR system 10 minutes before the start of the wound care, until 1 minute after the wound care has ended.

Device: Virtual Reality system
The intervention group 1 will be wearing the 'SyncVR' Virtual Reality system during the wound care moment in addition to the standard procedure. The VR system consists of Virtual Reality glasses, a controller, and a headphone. The SyncVR Relax & Distract Application (SyncVR R&D) will be used.

Experimental: Music Therapy (Intervention group 2)

In addition to the standard wound care procedure, the Music Therapy group (intervention group 2) will be hearing their preferred audio, chosen by patient to be relaxing and to offer distraction, through headphones during wound care. This group wears the headphone with music 10 minutes before the start of the wound care, until 1 minute after the wound care has ended.

Other: Headphones
Headphones with audio. The patients will be hearing their preferred audio, chosen by patient to relaxing and to offer distraction, through headphones during wound care.

No Intervention: Care as usual (control group/group 3)

The care as usual group (control group) will receive the care as usual. This group receives neither VRT nor MT during wound care.

Outcome Measures

Primary Outcome Measures

  1. The primary outcome is the change in pain score before and after the first wound care, measured with the Visual Analogue Scale (VAS). [Baseline, during the procedure, immediately after procedure]

    The VAS is a horizontal scale from 0 to 10, with 0 indicating ''no pain'' and 10 indicating ''worst pain possible''.

Secondary Outcome Measures

  1. Mean VAS change of all wound care procedures included in the study [Baseline, during the procedure, immediately after procedure]

    The VAS is a horizontal scale from 0 to 10, with 0 indicating ''no pain'' and 10 indicating ''worst pain possible''.

  2. Change from baseline in level of anxiety at 10 minutes after procedure [Baseline, 10 minutes after procedure]

    Level of anxiety, as measured by a Dutch translated and validated modification of the Spielberger State-Trait Inventory-6 (STAI-6) questionnaire 10 minutes before and 10 minutes after each three wound care moments.

  3. Patient satisfaction [Through study completion, an average of 1 week]

    Patient satisfaction, as measured by a self-developed Dutch provider satisfaction questionnaire, focuses on satisfaction about the intervention with the VR system or headphone with audio. The questionnaires included a Visual Analogue Scale (VAS). The VAS is a horizontal scale from 0 to 10, with 0 indicating ''the worst score'' and 10 indicating ''the best score'', or with 0 indicating '''the best score'' and 10 indicating ''the worst score''.

  4. Provider satisfaction [Through study completion, an average of 1 year]

    Provider satisfaction, as measured by a self-developed Dutch provider satisfaction questionnaire, focuses on satisfaction about the intervention with the VR system or headphone with audio. The questionnaires included a Visual Analogue Scale (VAS). The VAS is a horizontal scale from 0 to 10, with 0 indicating ''the worst score'' and 10 indicating ''the best score'', or with 0 indicating '''the best score'' and 10 indicating ''the worst score''.

  5. Change from baseline systolic blood pressure and diastolic blood pressure at 5 minutes after procedure [Baseline, 5 minutes after procedure]

    The systolic blood pressure and diastolic blood pressure 5 minutes before the intervention (intervention group)/wound care (control group) and 5 minutes after the intervention (intervention group)/wound care (control group)

  6. Change of systolic blood pressure and diastolic blood pressure during procedure [During procedure]

    The systolic blood pressure and diastolic blood pressure every 5 minutes during procedure

  7. Change from baseline blood oxygen level at 5 minutes after procedure [Baseline, 5 minutes after procedure]

    The blood oxygen level, measured using a pulse oximetry device, 5 minutes before intervention (intervention group)/wound care (control group), and 5 minutes after the intervention (intervention group)/wound care (control group)

  8. Change of blood oxygen level during procedure [During procedure]

    The blood oxygen level every 5 minutes during procedure, measured using a pulse oximetry device

  9. Change from baseline pulse rate at 5 minutes after procedure [Baseline, 5 minutes after procedure]

    The pulse rate 5 minutes before intervention (intervention group)/wound care (control group), and 5 minutes after the intervention (intervention group)/wound care (control group)

  10. Change of pulse rate during procedure [During procedure]

    The pulse rate every 5 minutes during procedure

  11. Change from baseline respiratory rate at 5 minutes after procedure [Baseline, 5 minutes after procedure]

    The respiratory rate 5 minutes before intervention (intervention group)/wound care (control group), and 5 minutes after the intervention (intervention group)/wound care (control group)

  12. Change of respiratory rate during procedure [During procedure]

    The respiratory rate every 5 minutes during procedure

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Individuals aged 18 or older who are admitted to the surgical nursing wards having wounds receiving wound care

  • Individuals who will undergo minimum of 1 to a maximum of 3 sequential complex wound care procedures before discharge

  • At least 1 prior painful wound care procedure, where they have indicated a VAS ≥ 4, or patients reporting a VAS ≥ 4 before initiating the wound care procedure.

Exclusion Criteria:
  • Individuals not being able to understand Dutch language at primary school level

  • Individuals not being able to read or write Dutch

  • Individuals diagnosed with dementia and/or cognitive impairment

  • Individuals diagnosed with epilepsy

  • Individuals diagnosed with autism

  • Individuals diagnosed with migraine

  • Individuals with severe dizziness and/or nausea

  • Individuals with a known history of claustrophobia

  • Individuals who are unable to sign informed consent owing to mental disorder or formally stated to be incompetent to decide

  • Individuals who have no feeling in the wound care area

  • Individuals with >1 wound requiring wound care

  • Individuals with physical (and/or cognitive) disabilities on the face, eye, ear, nose and neck that prevent the use of the VR headgear and/or headphones

Contacts and Locations

Locations

Site City State Country Postal Code
1 Amsterdam University Medical Center Amsterdam Noord-Holland Netherlands 1105AZ

Sponsors and Collaborators

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Investigators

  • Principal Investigator: Marlies Schijven, Prof. dr., Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Marlies P. Schijven, Professor doctor, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
ClinicalTrials.gov Identifier:
NCT05744024
Other Study ID Numbers:
  • NL82062.018.22
First Posted:
Feb 24, 2023
Last Update Posted:
Feb 24, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 24, 2023